Trial Profile
Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents (BIONYX): A Randomized Trial With Stent Evaluation in All-comers IV
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Zotarolimus
- Indications Coronary artery disease; Coronary artery restenosis; Myocardial infarction
- Focus Therapeutic Use
- Acronyms BIONYX; TWENTE IV
- 13 Jul 2021 Status changed from active, no longer recruiting to completed, according to Results published in the Circulation Journal.
- 13 Jul 2021 Results published in the Circulation Journal
- 17 May 2021 Results (N=2488) of an analysis assessing the 3-year outcome after percutaneous coronary intervention presented at the 70th Annual Scientific Session of the American College of Cardiology